Utama › Leukemia Biphenotipik Akut › Texas

Kajian klinikal Leukemia Biphenotipik Akut di Texas

13 kajian untuk Leukemia Biphenotipik Akut sedang mencari peserta di lokasi di Texas.

Bandar di Texas

Teks kajian rasmi (Bahasa Inggeris)

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

University of Texas MD Anderson Cancer Center, Houston

Mengambil pesertaFasa 1

Umur 12 hingga 78 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT03802695

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Dell Children's Medical Center of Central Texas, Austin
Driscoll Children's Hospital, Corpus Christi
Medical City Dallas Hospital, Dallas
dan 7 lagi

Mengambil pesertaFasa 2

365 Days · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06317662

Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation

M D Anderson Cancer Center, Houston

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT03683433

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Dell Children's Medical Center of Central Texas, Austin
Driscoll Children's Hospital, Corpus Christi
Medical City Dallas Hospital, Dallas
dan 12 lagi

Mengambil pesertaFasa 3

365 Days – 25 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Dell Children's Medical Center of Central Texas, Austin
Driscoll Children's Hospital, Corpus Christi
Medical City Dallas Hospital, Dallas
dan 10 lagi

Mengambil pesertaFasa 1/2

Sehingga umur 22 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04726241

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

University of Texas MD Anderson Cancer Center, Houston

Mengambil pesertaFasa 1/2

Umur 13 hingga 90 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT06533579

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

UT Southwestern/Simmons Cancer Center, Dallas
Cook Children's Medical Center, Fort Worth

Mengambil pesertaFasa 1

Umur 1 hingga 30 · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06177067

Personalized NK Cell Therapy in CBT

M D Anderson Cancer Center, Houston

Mengambil pesertaFasa 2

Umur 15 hingga 80 · Semua jantina · Dikemas kini 30 Jul 2026 · NCT02727803

A Study of Revumenib and Mezigdomide in People With Leukemia

MD Anderson Cancer Center (Data Collection Only), Houston

Mengambil pesertaFasa 1/2

Umur 12 ke atas · Semua jantina · Dikemas kini 22 Jun 2026 · NCT07356154

Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

M D Anderson Cancer Center, Houston

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 12 Jun 2026 · NCT04047641

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

M D Anderson Cancer Center, Houston

Mengambil pesertaFasa 2

Umur 18 hingga 65 · Semua jantina · Dikemas kini 20 Mei 2026 · NCT02115295

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

University of Texas(UT) Southwestern-Children's Medical Center, Dallas

Mengambil pesertaFasa 1/2

Umur 12 hingga 95 · Semua jantina · Dikemas kini 15 Apr 2026 · NCT04329728

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

University of Texas, Southwestern, Dallas
Cook Children's Hospital, Fort Worth
Texas Children's Hospital/Baylor College of Medicine, Houston

Mengambil pesertaFasa 1

Umur 1 hingga 21 · Semua jantina · Dikemas kini 6 Dis 2024 · NCT05476770

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.